Compare COR & VALE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COR | VALE |
|---|---|---|
| Founded | 2001 | 1942 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.5B | 63.7B |
| IPO Year | N/A | N/A |
| Metric | COR | VALE |
|---|---|---|
| Price | $359.25 | $16.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $391.31 | $14.40 |
| AVG Volume (30 Days) | 1.3M | ★ 43.8M |
| Earning Date | 02-04-2026 | 02-12-2026 |
| Dividend Yield | 0.67% | ★ 5.52% |
| EPS Growth | ★ 18.64 | N/A |
| EPS | ★ 8.33 | 1.32 |
| Revenue | ★ $325,777,775,000.00 | $40,027,019,862.00 |
| Revenue This Year | $7.19 | N/A |
| Revenue Next Year | $6.19 | $0.25 |
| P/E Ratio | $43.12 | ★ $12.36 |
| Revenue Growth | ★ 7.45 | 1.05 |
| 52 Week Low | $237.71 | $8.06 |
| 52 Week High | $377.54 | $17.34 |
| Indicator | COR | VALE |
|---|---|---|
| Relative Strength Index (RSI) | 52.37 | 62.49 |
| Support Level | $328.01 | $16.28 |
| Resistance Level | $362.35 | $17.16 |
| Average True Range (ATR) | 10.29 | 0.50 |
| MACD | -0.55 | -0.01 |
| Stochastic Oscillator | 67.02 | 72.24 |
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Vale is a large global miner and the world's largest producer of iron ore and pellets. In recent years the company has sold noncore assets such as its fertilizer, coal, and steel operations to concentrate on iron ore, nickel, and copper. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets. The base metals division is much smaller, consisting of nickel mines and smelters along with copper mines producing copper in concentrate. In 2024, Vale sold a minority 10% stake in energy transition metals, its base metals business, likely the first step in separating base metals and iron ore.